Back
SpringWorks Therapeutics Vs. Charles River Laboratories International Industry Stock Comparison
Sell
30
SWTX
SpringWorks Therapeutics
Last Price:
$46.14
Seasonality Move:
6.26%
Buy
52
CRL
Charles River Laboratories International
Last Price:
$143.78
Seasonality Move:
7.09%
Sell
30
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
-
The current SpringWorks Therapeutics [SWTX] share price is $46.26. The Score for SWTX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
SWTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Charles River Laboratories International (CRL)
is a Buy
Is Charles River Laboratories International a Buy, Sell or Hold?
-
The current Charles River Laboratories International [CRL] share price is $138.79. The Score for CRL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $46.26The current trend is moderately bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRL Stock Price Chart
What is Charles River Laboratories International's stock price today?
-
The Charles River Laboratories International share price today is $138.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing selling pressure, which indicates risk of future bearish movement.
SWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.92 | Buy |
| Relative Strength Index (14 RSI): | 58.93 | Buy |
| Chaikin Money Flow: | 3763838 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.28 - 46.02) | Buy |
| Bollinger Bands (100): | (36.18 - 50.8) | Buy |
CRL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.16 | Buy |
| Relative Strength Index (14 RSI): | 59.59 | Buy |
| Chaikin Money Flow: | -798786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.83 - 130.65) | Buy |
| Bollinger Bands (100): | (131.14 - 183.16) | Sell |
SWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.22 | Buy |
| 20-day SMA: | 42.89 | Buy |
| 50-day SMA: | 45.49 | Buy |
| 200-day SMA: | 39.59 | Buy |
| 8-day EMA: | 45.82 | Buy |
| 20-day EMA: | 44.45 | Buy |
| 50-day EMA: | 44.27 | Buy |
| 200-day EMA: | 41.4 | Buy |
CRL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.74 | Buy |
| 20-day SMA: | 115.49 | Buy |
| 50-day SMA: | 140.7 | Sell |
| 200-day SMA: | 179 | Sell |
| 8-day EMA: | 128.43 | Buy |
| 20-day EMA: | 120.11 | Buy |
| 50-day EMA: | 95.54 | Buy |
| 200-day EMA: | 38.76 | Buy |
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $1.44 per share.
Charles River Laboratories International Earnings Growth & CRL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.58 per share, and an increase next year of $0.66 per share.
SpringWorks Therapeutics Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Charles River Laboratories International Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||